x
African Health Sciences
[contact-form-7 id="2459" title="Sidebar Form"]

  • 256(41)530021
  • info@africanhealthsciences.org
African Health Sciences
  • info@africanhealthsciences.org
  • Give Feedback
  • Home
  • About Us
  • Staff
  • Focus & Scope
  • For Authors
  • More Links
    • About The Journal
    • Latest Articles
    • Journal Archives
    • Our Events
    • Faq’s
  • Contact Us
Logo

Contact Info

  • P. O. Box 7072 Kampala, Uganda
  • +256(41)530021
  • info@africanhealthsciences.org
  • ISSN 1680-6905
  • <!--
  • -->

30Oct2017

Prevalence of anaemia

by admin,  0 Comments

Prevalence of anaemia and immunological markers among Ghanaian HAART-naïve HIV-patients and those on HAART

WKBA Quaye, AN Addai-Mensah

Abstract

Background: Highly active antiretroviral therapy (HAART) for people living with HIV/AIDS (PLWHA) has been generally accepted as the gold standard for the management of HIV patients but conflicting reports about the ability of HAART to improve upon the quality of life of HIV patients has cast doubts over the efficacy and the need for therapy.

Objective: This study was conducted to assess the efficacy and ability of HAART to resolve immunological and haematological abnormalities in HIV infected patients, existent sex variations in immunological and haematological parameters and CD4 predictive ability of the study parameters.

Methods: A total of 442 PLWHA consisting of 166 patients on HAART (28 males and 138 females) and 276 HAARTnaive patients (76 males and 200 females) were recruited for this study. Complete haemogram, immunological analysis (CD4 & CD3) and weight were measured for all the patients.

Results: HAART patients were older and heavier than their naive counterparts. The incidence of anaemia (Hb less or equal to 10.5 (63%) and PCV < 30% (37.6%)) and lymphopoenia (16.7%) in HAART-naive patients was significantly higher compared to their counterparts on HAART (46%, 15.2% and 5.3%) respectively. 70% of HAART-naive females had anaemia in comparison to 44% in HAART-naive males (P = 0.0001). The likelihood of developing microcytic hypochromic anaemia in HAART-naive patients was 5 times more compared to those on HAART (P = 0.0002). Total lymphocyte count, haemoglobin, lymphocyte count and weight were significant predictors of CD4 counts and TLC values between 1.0 . 2.0 k ƒÊL-1 was a significant predictor of CD4 <200 cells mm-3.

Conclusion: HAART has the capability of reducing the incidence of anaemia and lymphopoenia which are associated with disease progression and death in HIV infected patients. Total lymphocyte count, haemoglobin and weight could also serve as useful predictive tools in the management and monitoring of HIV infected patients in resource limited settings.

 

Related posts:

practice of exclusive breastfeeding

Factorial validation and reliability analysis

Uterine Leiomyomata in South Western Nigeria

Recent Posts

  • Editor’s choice: Tackling infectious diseases, NCDs and sexual reproductivehealth issues as we enter our 24th year of remarkable growth
  • Preconception and contraceptive care for women living with HIV/AIDSattending antiretroviral treatment clinics in Lagos State, Nigeria
  • Effects of SNPs on TNF-α and IL-10 cytokine expression in TB and HIVpatients in the Capricorn district, Limpopo Province, South Africa
  • Prevalence of Schistosomiasis in a neglected community, South western Nigeria at two points in time, spaced three years apart
  • Review of Leishmaniasis in the Middle East and North Africa

Recent Comments

No comments to show.

Archives

  • April 2024
  • May 2019
  • April 2019
  • September 2018
  • August 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017

Categories

  • 2001 Issues
  • 2002 Issues
  • 2003 Issues
  • 2004 Issues
  • 2005 Issues
  • 2006 Issues
  • 2007 Issues
  • 2008 Issues
  • 2009 Issues
  • 2010 Issues
  • 2011 Issues
  • 2012 Issues
  • 2013 Issues
  • 2014 Issues
  • 2015 Issues
  • 2016 Issues
  • 2017 Issues
  • 2018 Issues
  • 2019 Issues
  • 2024 Issues
  • Articles
  • December issue
  • December Release
  • June Issue
  • June Release
  • March Issue
  • March Issue
  • March Release
  • News
  • number / volume 2
  • number /volume 1
  • number /volume 1
  • number /volume 1 2008
  • number 1
  • number 1
  • number 1
  • number 1
  • number 1
  • number 1
  • number 1
  • number 2
  • number 2
  • number 2
  • number 2
  • number 2
  • number 2
  • number 2
  • number 2 special Issue
  • number 2 special Issue 2
  • number 3
  • number 3
  • number 3
  • number 3
  • number 3
  • number 3
  • number 3
  • number 4
  • number 4
  • number 4
  • number 4
  • number 4
  • number 4
  • number/ volume 3 2008
  • number/ volume 4 2008
  • number/volume 1
  • number/volume 1
  • number/volume 2
  • number/volume 2
  • number/volume 2 2008
  • number/volume 3
  • number/volume 3
  • number/volume 3
  • number/volume 4
  • number/volume1
  • September Issue
  • September Release
  • Special Edition
  • special Issue
  • Uncategorized
  • Vol. 24 No. 1 (2024)
  • volume 1
  • volume 1
  • volume 1
  • volume 2
  • volume 2
  • volume 2
  • volume 2
  • volume 2
  • volume 3
  • volume 3
  • volume 3
  • volume 3
  • volume 4
  • volume 4
  • volume 4
  • volume 4
  • volume1

Categories

  • 2001 Issues
  • 2002 Issues
  • 2003 Issues
  • 2004 Issues
  • 2005 Issues
  • 2006 Issues
  • 2007 Issues
  • 2008 Issues
  • 2009 Issues
  • 2010 Issues
  • 2011 Issues
  • 2012 Issues
  • 2013 Issues
  • 2014 Issues
  • 2015 Issues
  • 2016 Issues
  • 2017 Issues
  • 2018 Issues
  • 2019 Issues
  • 2024 Issues
  • Articles
  • December issue
  • December Release
  • June Issue
  • June Release
  • March Issue
  • March Issue
  • March Release
  • News
  • number / volume 2
  • number /volume 1
  • number /volume 1
  • number /volume 1 2008
  • number 1
  • number 1
  • number 1
  • number 1
  • number 1
  • number 1
  • number 1
  • number 2
  • number 2
  • number 2
  • number 2
  • number 2
  • number 2
  • number 2
  • number 2 special Issue
  • number 2 special Issue 2
  • number 3
  • number 3
  • number 3
  • number 3
  • number 3
  • number 3
  • number 3
  • number 4
  • number 4
  • number 4
  • number 4
  • number 4
  • number 4
  • number/ volume 3 2008
  • number/ volume 4 2008
  • number/volume 1
  • number/volume 1
  • number/volume 2
  • number/volume 2
  • number/volume 2 2008
  • number/volume 3
  • number/volume 3
  • number/volume 3
  • number/volume 4
  • number/volume1
  • September Issue
  • September Release
  • Special Edition
  • special Issue
  • Uncategorized
  • Vol. 24 No. 1 (2024)
  • volume 1
  • volume 1
  • volume 1
  • volume 2
  • volume 2
  • volume 2
  • volume 2
  • volume 2
  • volume 3
  • volume 3
  • volume 3
  • volume 3
  • volume 4
  • volume 4
  • volume 4
  • volume 4
  • volume1

Archives

  • April 2024
  • May 2019
  • April 2019
  • September 2018
  • August 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017

Tags

Achives Latest News


ISSN 1680-6905

  • P. O. Box 7072 ,Kampala, Uganda
  • Call Us: 256(41)530021
  • info@africanhealthsciences.org

Latest Activities

Usefull Link

  • About AHS
  • Services
  • Focus & Scope
  • Our Articles
  • Contact Us

Subscribe

For research updates from African Health Sciences, sign up now!

[contact-form-7 id="1620" title="Subscribe"]

African Health Sciences © All Right Reserved